Navigate Fool.com
Will MELA beat
the market?


Community Rating: 1 Star: Ominous

2.48 -0.33 (-11.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.68
Previous Close $2.81
Daily Range $2.45 - $2.68
52-Week Range $1.98 - $10.40
Market Cap $12.9M
P/E Ratio -0.48
Dividend (Yield) $0.00 (0.0%)
Volume 271,369
Average Daily Volume 44,268
Current FY EPS $0.00

How do you think MELA
will perform against the market?

Top MELA Bull/Bear Pitches


FWWright (13.7)
Submitted June 15, 2012

I have had skin cancer and will have more and am waiting for my dermatologist to buy a non-invasive tester so he doesn't just freeze everything off or in the worse looking ones have me make a separate … More

0 Replies Reply Report this Post

markofzorro (< 20)
Submitted May 19, 2010

Based on MELA's press release, it is unclear if MelaFind will find new cases of melanoma that dermatologists don't already suspect. MELA's study was done in people the dermatologists already suspected … More

9 Replies Reply Report this Post

News & Commentary

Buy, Sell, or Hold: MELA Sciences

Do the benefits here outweigh the risks?

Blue Chips And Investment Trusts Among This Fund's Top Picks

The Barclays Triggers More Insider Buying

Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC)

How Global Growth of Cancer Can Make You Money

This Just In: Upgrades and Downgrades

Everybody's down on Dendreon, lately.

2 Stocks Stopping the Presses

These companies made big headlines -- what does it mean to you?

Here's What George Soros Has Been Buying and Selling

Take a peek at what the smartest investors are doing.

This Just In: Upgrades and Downgrades

ThinkEquity says Intuitive Surgical is a no-brainer. Is it right?

Mark Your Calendars, Biotech Investors

Cell Therapeutics' advisory panel meet ought to be entertaining.

See More MELA News...




Healthcare Information Services

MELA Sciences (MELA) Description

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. Website: http://www.melasciences.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks